Table 1.
The characteristics of study subjects by metabolic syndrome status.
| Please Be Variable | Total | Nonmetabolic Syndrome Group |
Metabolic Syndrome Group |
p-Value |
|---|---|---|---|---|
| (n = 396) | (n = 213) | (n = 183) | ||
| Homocysteine (µmol/L) | 13.60 ± 4.90 | 12.97 ± 4.64 | 14.34 ± 5.10 | <0.001 |
| FPG (mg/dL) | 109.79 ± 35.65 | 99.27 ± 30.97 | 122.02 ± 36.90 | <0.001 |
| ALT (U/L) | 27.16 ± 22.82 | 25.06 ± 20.85 | 29.60 ± 24.76 | <0.001 |
| Creatinine (mg/dL) | 0.87 ± 0.43 | 0.85 ± 0.54 | 0.89 ± 0.26 | <0.001 |
| HDL-C(mg/dL) | 53.65 ± 14.66 | 58.77 ± 14.09 | 47.49 ± 12.54 | <0.001 |
| LDL-C (mg/dL) | 109.69 ± 33.99 | 113.36 ± 33.55 | 105.42 ± 34.10 | <0.001 |
| Triglycerides (mg/dL) | 141.07 ± 110.00 | 101.75 ± 41.20 | 186.85 ± 142.72 | 0.006 |
| Uric acid (mg/dL) | 5.63 ± 1.52 | 5.32 ± 1.34 | 6.00 ± 1.63 | 0.006 |
| Waist circumference (cm) | 85.36 ± 10.83 | 81.12 ± 10.01 | 90.28 ± 9.62 | 0.048 |
| SBP (mmHg) | 137.30 ± 17.49 | 134.07 ± 17.62 | 141.07 ± 16.61 | 0.051 |
| DBP (mmHg) | 85.19 ± 10.98 | 83.37 ± 10.91 | 87.31 ± 10.70 | 0.371 |
| Age (year) | 64.80 ± 8.77 | 63.23 ± 9.38 | 64.28 ± 7.96 | 0.349 |
| BMI (kg/m2) | 25.59 ± 3.84 | 24.00 ± 3.10 | 27.45 ± 3.79 | 0.001 |
| Smoking, n (%) | 50 (12.6) | 21 (9.9) | 29 (15.8) | 0.074 |
| Alcohol consumption, n (%) | 28 (7.1) | 10 (4.7) | 18 (9.8) | 0.047 |
| Hypertension, n (%) | 201 (50.8) | 71 (33.3) | 130 (71.0) | <0.001 |
| Diabetes mellitus, n (%) | 133 (33.6) | 40 (18.8) | 93 (50.8) | <0.001 |
| Dyslipidemia, n (%) | 153 (38.6) | 57 (26.8) | 96 (52.5) | <0.001 |
| Gender (men), n (%) | 164 (41.4) | 83 (39.0) | 81 (44.3) | 0.287 |
Note: Data are expressed as the mean ± SD for continuous variables and n (%) for categorical variables. Abbreviations: FPG, fasting plasma glucose; HDL-C, high-density lipoprotein; LDL-C, low-density lipoprotein; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index.